IMPROVEMENT OF INSULIN-INDUCED GLUCOSE DISPOSAL IN OBESE PATIENTS WITH NIDDM AFTER 1-WK TREATMENT WITH D-FENFLURAMINE

被引:78
作者
SCHEEN, AJ [1 ]
PAOLISSO, G [1 ]
SALVATORE, T [1 ]
LEFEBVRE, PJ [1 ]
机构
[1] CHU SART TILMAN B35, DEPT MED, DIV DIABET NUTR & METAB DISORDERS, B-4000 LIEGE 1, BELGIUM
关键词
D O I
10.2337/diacare.14.4.325
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To study the short-term effects of the serotoninergic anorectic drug d-fenfluramine on insulin-induced glucose disposal. Research Design and Methods: A randomized double-blind placebo-controlled crossover trial with 1-wk treatment periods (2 x 15 mg/day d-fenfluramine) was conducted. Twenty obese subjects, 10 with normal oral glucose tolerance and 10 with non-insulin-dependent diabetes mellitus (NIDDM), were all treated with a weight-maintaining diet. Euglycemic-hyperinsulinemic glucose clamps with measurement of glucose kinetics with D-[3-H-3]glucose were performed at either two (patients without NIDDM, 0.05 and 0.10 U.kg-1.h-1) or three (patients with NIDDM, 0.05, 0.10, and 0.50 U.kg-1.h-1) insulin delivery rates. Results: In the nondiabetic subjects, no significant changes in any metabolic or hormonal parameter were measured in the basal state or during the clamp despite a slight reduction in body weight (-1.2 +/- 0.5 kg, P < 0.05). In the diabetic patients, no significant changes in body weight or basal plasma insulin levels were observed, but fasting blood glucose levels (8.0 +/- 0.8 vs. 9.4 +/- 1.1 mM, P < 0.005) and plasma free fatty acid concentrations (1150 +/- 227 vs. 1640 +/- 184-mu-M, P < 0.05) were significantly reduced after d-fenfluramine compared with placebo. During the clamp, insulin metabolic clearance rate (MCR) was similar after both placebo and d-fenfluramine; endogenous (hepatic) glucose production was similarly and almost completely suppressed, whereas glucose disposal was remarkably enhanced after d-fenfluramine (average increase of glucose MCR 35 +/- 12%, P < 0.02). Conclusions: Whatever the mechanism(s) involved, a 1-wk treatment with d-fenfluramine induces better blood glucose control and improves insulin sensitivity in obese patients with NIDDM independent of significant weight reduction; this last effect is not present in obese subjects with normal oral glucose tolerance.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 33 条
[1]  
BUTTERFIELD WJ, 1968, LANCET, V2, P109
[2]   NONSTEADY STATE - ERROR ANALYSIS OF STEELES MODEL AND DEVELOPMENTS FOR GLUCOSE KINETICS [J].
COBELLI, C ;
MARI, A ;
FERRANNINI, E .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (05) :E679-E689
[3]  
DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
[4]  
DOLE VP, 1960, J BIOL CHEM, V235, P2595
[5]   EFFECT OF A LOW-CALORIE DIET WITH AND WITHOUT FENFLURAMINE ON GLUCOSE-TOLERANCE AND INSULIN-SECRETION OF OBESE MATURITY-ONSET DIABETICS [J].
DYKES, JRW .
POSTGRADUATE MEDICAL JOURNAL, 1973, 49 (571) :318-324
[6]  
Eggstein M., 1974, METHOD ENZYMAT AN, V4, P1825
[7]   ROLE OF LIPID OXIDATION IN PATHOGENESIS OF INSULIN RESISTANCE OF OBESITY AND TYPE-II DIABETES [J].
FELBER, JP ;
FERRANNINI, E ;
GOLAY, A ;
MEYER, HU ;
THEIBAUD, D ;
CURCHOD, B ;
MAEDER, E ;
JEQUIER, E ;
DEFRONZO, RA .
DIABETES, 1987, 36 (11) :1341-1350
[8]  
FERRANNINI E, 1983, AM J PHYSIOL, V244, pE517
[9]   GLUCOSE AND FREE FATTY-ACID METABOLISM IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - EVIDENCE FOR MULTIPLE SITES OF INSULIN RESISTANCE [J].
GROOP, LC ;
BONADONNA, RC ;
DELPRATO, S ;
RATHEISER, K ;
ZYCK, K ;
FERRANNINI, E ;
DEFRONZO, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (01) :205-213
[10]   IMMUNOASSAY OF INSULIN WITH INSULIN-ANTIBODY PRECIPITATE [J].
HALES, CN ;
RANDLE, PJ .
BIOCHEMICAL JOURNAL, 1963, 88 (01) :137-&